You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 149 No. 10, October 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (108)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Heparin Therapy During Pregnancy

Risks to the Fetus and Mother

J. S. Ginsberg, MD; G. Kowalchuk; J. Hirsh, MD; P. Brill-Edwards, MD; R. Burrows, MD

Arch Intern Med. 1989;149(10):2233-2236.


Abstract

• The true maternal and fetal risks of heparin therapy during pregnancy are unknown, because most published studies are small and do not report consecutively treated patients. In order to address these issues, we performed a retrospective cohort study of 100 pregnancies in 77 women treated with heparin during pregnancy. In 98 pregnancies heparin therapy was given for the prevention or treatment of venous thromboembolism; in the remaining 2, because of prosthetic heart valves. The rates of prematurity, abortions, stillbirths, neonatal deaths, and congenital abnormalities were similar to those in the normal population. There were two bleeding episodes and no symptomatic thrombotic episodes associated with heparin therapy. We conclude that maternal heparin therapy is safe for the fetus and is associated with an acceptable bleeding rate and a low rate of thrombotic recurrence in the mother.

(Arch Intern Med. 1989;149:2233-2236)



Author Affiliations

From the Departments of Medicine (Drs Ginsberg, Kowalchuk, Hirsh, and Brill-Edwards) and Obstetrics and Gynecology (Dr Burrows), McMaster University, Hamilton, Canada.


Footnotes

Accepted for publication May 5,1989.

Reprint requests to the Department of Medicine, McMaster University, 1200 Main St W, Rm 3W12, Hamilton, Ontario, Canada L8N 3Z5 (Dr Ginsberg).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Venous Thromboembolism in Pregnancy
James
Arterioscler. Thromb. Vasc. Bio. 2009;29:326-331.
ABSTRACT | FULL TEXT  

Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Bates et al.
Chest 2008;133:844S-886S.
ABSTRACT | FULL TEXT  

Anticoagulation for Prosthetic Heart Valves in Pregnancy. Is There an Answer?
Khamooshi et al.
Asian Cardiovasc. Thorac. Ann. 2007;15:493-496.
ABSTRACT | FULL TEXT  

Management of Pregnant Women with Thrombophilia or a History of Venous Thromboembolism
Bates
ASH Education Book 2007;2007:143-150.
ABSTRACT | FULL TEXT  

A Protocol for the Use of Enoxaparin During Pregnancy: Results from 85 Pregnancies Including 13 Multiple Gestation Pregnancies
Huxtable et al.
CLIN APPL THROMB HEMOST 2005;11:171-181.
ABSTRACT  

Use of Antithrombotic Agents During Pregnancy: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Bates et al.
Chest 2004;126:627S-644S.
ABSTRACT | FULL TEXT  

Anticoagulation of Pregnant Women With Mechanical Heart Valves
Ginsberg et al.
Arch Intern Med 2003;163:694-698.
ABSTRACT | FULL TEXT  

How we manage venous thromboembolism during pregnancy
Bates and Ginsberg
Blood 2002;100:3470-3478.
ABSTRACT | FULL TEXT  

Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology
Eur Heart J 2001;22:1852-1923.
 

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
Fuster et al.
J Am Coll Cardiol 2001;38:1266-1266.
FULL TEXT  

Use of Antithrombotic Agents During Pregnancy
Ginsberg et al.
Chest 2001;119 :122S-131S.
FULL TEXT  

Thrombophilia in pregnancy
Walker
J. Clin. Pathol. 2000;53:573-580.
ABSTRACT | FULL TEXT  

The Effects of Immunosuppressive and Anti-inflammatory Medications on Fertility, Pregnancy, and Lactation
Janssen and Genta
Arch Intern Med 2000;160:610-619.
ABSTRACT | FULL TEXT  

Venous Thromboembolism during Pregnancy
Toglia and Weg
NEJM 1996;335:108-114.
FULL TEXT  

Management of Deep Vein Thrombosis and Pulmonary Embolism : A Statement for Healthcare Professionals From the Council on Thrombosis (in Consultation With the Council on Cardiovascular Radiology), American Heart Association
Hirsh and Hoak
Circulation 1996;93:2212-2245.
FULL TEXT  

Recent Developments in the Diagnosis, Treatment, and Prevention of Pulmonary Embolism
Hastings et al.
Arch Fam Med 1993;2:655-669.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.